Skip to content

Clinical trials

Completed Hepatitis B trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Status: Completed Country / region: Germany Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20053
20067
20074
20084
20091
20103
20112
20131
20142
20161
20171
20181
20202
20213
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline25
Gilead Sciences7
Dynavax Technologies Corporation2
Vir Biotechnology, Inc.2
Bristol-Myers Squibb1
Heinrich-Heine University, Duesseldorf1
HepNet Study House, German Liverfoundation1
Janssen Research & Development, LLC1
Janssen Sciences Ireland UC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B45
Hepatitis B, Chronic11
Diphtheria7
Hepatitis7
Tetanus7
Haemophilus Infections6
Poliomyelitis6
Hepatitis A3
Whooping Cough3
Hepatitis, Chronic2

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.